JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Tel: +1-832-696-8203
Email: [email protected]
Worldwide Distributors
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
Sitafloxacin is anantibiotic against gram-positive, gram-negativeand anaerobebacteria[1].
Sitafloxacin is a novel fluoroquinolone antibiotic with a broad antibacterial spectrum. It has activity against Enterobacterial species (gram-positive bacteria) with MIC50 values ranging from 0.008 to 1mg/ml and MIC90 values ranging from 0.015 to 2mg/ml. For the gram-negative bacteria, sitafloxacinis are found to be above eight-fold effective than ciprofloxacin against Acinetobacter spp. with MIC values ranging from 0.008 to 8mg/ml. Besides, sitafloxacinis are reported to inhibit anaerobic bacteria including Bacteroides species, Clostridium perfringens and Peptostreptococcus spp. with the MIC50 values ranging from 0.03 to 0.12mg/ml and MIC90 values ranging from 0.06 to 0.25 mg/ml [1].
References:[1] Milatovic D1, Schmitz FJ, Brisse S, Verhoef J, Fluit AC. In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates.Antimicrob Agents Chemother. 2000 Apr;44(4):1102-7.
